glp-1 therapy weight loss milestones timeline The Timeline: What to Expect in Your First Year Safety and Tolerability of Glucagon-Like

The development of multi-agonists with multi-organ targets may alter the natural history of these diseases

The following search terms were used: (exenatide OR liraglutide OR albiglutide OR dulaglutide OR lixisenatide OR semaglutide OR tirzepatide OR GLP-1 RAs OR Glucagon-like peptide-1 receptor agonist) AND (acute pancreatitis) AND (case report OR case series)

R., Janus, C., Jensen, S

3.4 Appetite regulation and weight management Similar to animal studies with deletion of the GIPR gene that exhibit protection toward obesity (53), early genome-wide association studies (GWAS) in humans have revealed the GIPR gene to be associated with BMI (103)